Companies · Other Health Care

Vital Connect, Inc.

SAN JOSE · Other Health Care

Diligence memoA one-page analyst read on Vital Connect, Inc. — recommendation, valuation, rhythm, risks.
$105.7M
Total raised · real
4
Rounds
1.0×
Latest step-up
Top 5%
Sector rank · raised
Series B
Latest stage · inferred · Thu Dec 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Vital Connect, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.47× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
  • Within the normal band (147% of peer median) for its niche.
Dormant
  • Last raise 4.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Vital Connect, Inc. is one of 5377 Other Health Care companies tracked from SAN JOSE. By capital raised it ranks among the largest (ahead of 96% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
63
Investors (latest)
2021-12-23
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2011-10-31 Raised $11M (real) Modeled valuation $217M (est)Series A2011Series B · 2013-04-10 Raised $18M (real) Modeled valuation $398M (est)Series B2013Seed · 2013-04-10 Raised $3.2M (real) Modeled valuation $79M (est)Seed2013Series A · 2013-04-10 Raised $7.3M (real) Modeled valuation $148M (est)Series A2013Series B · 2017-05-19 Raised $30M (real) Modeled valuation $671M (est)Series B2017Series B · 2017-05-19 Raised $38M (real) Modeled valuation $844M (est)Series B2017Series B · 2021-12-23 Raised $39M (real) Modeled valuation $549M (est)Series B2021+$18M+$3.2M+$7.3M+$30M+$38M+$39MCumulative $147M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$10.8M · 2011
Series B$18.0M · 2013
Bridge · Series B-stage$3.2M · 2013smaller follow-on
Bridge · Series B-stage$7.3M · 2013smaller follow-on
Series B extension$30.3M · 2017
Series B extension$38.1M · 2017
Series B extension$38.9M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$548.9M
Base estimate est.
$91.4M
Conservative case
$1.6B
Upside case
$216.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $217.1M · 2011-10-312011Series B · modeled $398.4M · 2013-04-10Seed · modeled $79.3M · 2013-04-10Series A · modeled $147.8M · 2013-04-10Series B · modeled $670.8M · 2017-05-19Series B · modeled $843.8M · 2017-05-19Series B · modeled $548.9M · 2021-12-232021
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
4.5 yr
Elapsed time used
4.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
20 mo
Avg between rounds
$10.4M/yr
Capital velocity
14.7 yr
On record since
2011
First round
7
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 44× above median
This company$105.7M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 2.2× above median
This company$38.9M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 25× above median
This company$548.9M
Sector median$22.1M

Raised more than 96% of sector peers (real $). Modeled value above 94% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #18 of 78.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)KSMS Holdings, LLC · Series B Raised $40.0M · modeled $885.1M (est)Infab HoldCo, Inc. · Series B Raised $36.5M · modeled $807.5M (est)Aquity Holdings, Inc. · Series B Raised $36.0M · modeled $797.6M (est)MHH Management Holdco, LLC · Series B Raised $35.1M · modeled $777.6M (est)Earli Inc. · Series B Raised $40.0M · modeled $757.1M (est)Encore Dermatology, Inc. · Series B Raised $89.6M · modeled $729.9M (est)National Spine & Pain Centers Holdings, LLC · Series B Raised $32.0M · modeled $708.9M (est)In Vitro Sciences, LLC · Series B Raised $31.5M · modeled $697.9M (est)Lotus Parent, Inc. · Series B Raised $31.2M · modeled $690.4M (est)Iron Oak Holdings LLC · Series B Raised $30.0M · modeled $664.6M (est)Squid Ink, Inc. · Series B Raised $30.2M · modeled $621.4M (est)Predict Innovation Investors, Llc · Series B Raised $27.9M · modeled $617.4M (est)Vital Connect, Inc. (this company) Raised $105.7M · modeled $548.9M (est)Vital Connect, Inc.
CompanyStageRaised · realValue · estvs peer med.
KSMS Holdings, LLCSeries B$40.0M$885.1M2.36×
Infab HoldCo, Inc.Series B$36.5M$807.5M2.16×
Aquity Holdings, Inc.Series B$36.0M$797.6M2.13×
MHH Management Holdco, LLCSeries B$35.1M$777.6M2.08×
Earli Inc.Series B$40.0M$757.1M2.02×
Encore Dermatology, Inc.Series B$89.6M$729.9M1.95×
National Spine & Pain Centers Holdings, LLCSeries B$32.0M$708.9M1.89×
In Vitro Sciences, LLCSeries B$31.5M$697.9M1.86×
Lotus Parent, Inc.Series B$31.2M$690.4M1.84×
Iron Oak Holdings LLCSeries B$30.0M$664.6M1.78×
Squid Ink, Inc.Series B$30.2M$621.4M1.66×
Predict Innovation Investors, LlcSeries B$27.9M$617.4M1.65×
Vital Connect, Inc. this companySeries B$105.7M$548.9M1.47×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$10.8M2011-10-31$48.9M$217.1M85%
Series B$18.0M2013-04-10$99.9M$398.4M85%
Seed$3.2M2013-04-10$16.0M$79.3M85%
Series A$7.3M2013-04-10$33.3M$147.8M85%
Series B$30.3M2017-05-19$168.2M$670.8M90%
Series B$38.1M2017-05-19$211.6M$843.8M90%
Series B$38.9M2021-12-23$216.0M$548.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$10.8M2011-10-31
    • First recorded raise — entered as Series A.
    • 23 investors on this round.
  2. Series B$18.0M2013-04-10
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 27 investors on this round.
  3. Seed$3.2M2013-04-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 5.6× smaller than the prior — bridge or down round.
    • Switched to Rule 06 (was Rule 506(b)).
    • 4 investors on this round.
  4. Series A$7.3M2013-04-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.3× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 12 investors on this round.
  5. Series B$30.3M2017-05-19
    • Raised again after 49 mo — slower than the ~14 mo sector norm.
    • Round 4.1× larger than the prior — scaling up.
    • 33 investors on this round.
  6. Series B$38.1M2017-05-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 48 investors on this round.
  7. Series B$38.9M2021-12-23
    • Raised again after 55 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 63 investors on this round.
Intelligence
2023 ~Q3
Modeled next raise · ~20mo cadence
$39.7M
Modeled next size est.range $38.9M$63.5M
1.0×
Last step-up
$10.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Stephen Reeders8 other2017-05
Robert White7 other2021-12
JOSEPH LEVINE1 other2021-12
Martyn Webster1 other2017-05
Nersi Nazari1 other2011-10
Steve Zadig1 other2011-10
Antonius Kufferath2021-12
James McCluney2017-05
Nathan Weems2021-12
Peter Van Haur2021-12
Richard Feachem2013-04
Saeed Azimi2011-10
Thomas Saunders, III2021-12
Tom Saunders2013-04
Registry & provenance

Vital Connect, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1534970
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
AccuVein Inc.Other Health CareSeries B$64.0M$53.5Mnetwork1 shared operator · same sector · same stage
Invuity, Inc.Other Health CareSeries B$105.7M$507.3Msame sector · same stage
Sotera Wireless, Inc.Other Health CareSeries B$98.5M$705.3Msame sector · same stage
Headspace, Inc.Other Health CareSeries B$115.9M$860.6Msame sector · same stage
iRhythm Technologies, Inc.Other Health CareSeries B$118.6M$605.8Msame sector · same stage
Neuronetics, Inc.Other Health CareSeries B$118.7M$332.3Msame sector · same stage
Medrobotics CorpOther Health CareSeries B$93.9M$443.1Msame sector · same stage
CDRT Holding CorpOther Health CareSeries B$92.5M$729.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Vitalchat, Inc.Other Health CareSeed$6.8M90%
VitalFlo Inc.Other Health CareSeed$36.0M89%
VitalCare Holdco, Inc.Other Health CareSeed$4.9M88%
Infectious Disease Connect, Inc.Other Health CareSeries A$13.9M87%
Vital Metrix Inc.Other Health CareSeed$74.3M87%
PERSOWN Connect, Inc.Other Health CarePre-Seed$566K86%
ConnectRN, Inc.Other Health CareSeries C$1.2B86%
Band Connect Inc.Other Health CareSeed$5.6M85%
Frequently asked
How much funding has Vital Connect, Inc. raised?
Vital Connect, Inc. has raised approximately $105.7M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Vital Connect, Inc.'s estimated valuation?
Provath's modeled valuation for Vital Connect, Inc. is approximately $548.9M (modeled range $91.4M–$1.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Vital Connect, Inc. at?
Vital Connect, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Thu Dec 23.
What does Vital Connect, Inc. do and where is it based?
Vital Connect, Inc. operates in the Other Health Care sector, based in SAN JOSE.
Explore related

See where Vital Connect, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Vital Connect, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.